Biogen (BIIB) EBITDA (2009 - 2026)
Biogen (BIIB) posted EBITDA of $232.1 million for Q3 2026, down 69.4% from $759.5 million a year earlier and down 37.0% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) EBITDA (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBITDA at Biogen was $1.33 billion, down 50.3% year-over-year; for FY2025, it came in at $2.34 billion, down 9.4% from FY2024.
- Annual EBITDA shows a five-year compound annual growth rate of -14.1% (FY2020 to FY2025).
- In prior years, Biogen's EBITDA was $2.58 billion in FY2024 (+44.0%), $1.79 billion in FY2023 (-56.4%), $4.11 billion in FY2022 (+23.5%) and $3.33 billion in FY2021 (-33.5%).
- Quarterly EBITDA has run from a low of -$16.2 million in Q3 2023 to a high of $1.49 billion in Q3 2022 over five years.
- On a year-over-year basis, EBITDA increased in four of the last eight quarters, with an average decline of 20.2%.
- The strongest year-over-year quarter for EBITDA in the past five years was Q2 2022, with growth of 132.9%; the weakest was Q4 2025, with a decline of 69.7%.
- According to Business Quant data, EBITDA for the three prior quarters was $368.5 million (Q2 2026), $582.1 million (Q1 2026) and $144.2 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | 232.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 232.10 Mn |
| Jun 30, 2026 | 368.50 Mn |
| Mar 31, 2026 | 582.10 Mn |
| Dec 31, 2025 | 144.20 Mn |
| Sep 30, 2025 | 759.50 Mn |
| Jun 30, 2025 | 938.30 Mn |
| Mar 31, 2025 | 494.40 Mn |
| Dec 31, 2024 | 475.50 Mn |
| Sep 30, 2024 | 633.80 Mn |
| Jun 30, 2024 | 857.60 Mn |
| Mar 31, 2024 | 612.30 Mn |
| Dec 31, 2023 | 431.70 Mn |
| Sep 30, 2023 | -16.20 Mn |
| Jun 30, 2023 | 825.50 Mn |
| Mar 31, 2023 | 550.60 Mn |
| Dec 31, 2022 | 723.60 Mn |
| Sep 30, 2022 | 1.49 Bn |
| Jun 30, 2022 | 1.40 Bn |
| Mar 31, 2022 | 753.80 Mn |
| Dec 31, 2021 | 721.80 Mn |
API Access
Biogen EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();